Stock listing

Xtl Biopharmaceuticals Ltd.

Selected listing: A41X7J · LSX · EUR · DE

Xtl Biopharmaceuticals Ltd. (LS Exchange: A41X7J), Health Technology. Latest release Apr 29, 2026: XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing…

A41X7J:LSXEURDEUpdated September 25, 2026

Ticker: LS Exchange: A41X7J
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: LS Exchange
Currency: EUR

Latest news from Xtl Biopharmaceuticals Ltd.

XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies

April 29, 2026

XTL Biopharmaceuticals Announces ADS Ratio Change

March 20, 2026

XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing

February 27, 2026

XTL Update on Recent Developments

January 29, 2026

XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Deficiency

January 23, 2026

All Xtl Biopharmaceuticals Ltd. news →

Research Xtl Biopharmaceuticals Ltd.

Xtl Biopharmaceuticals Ltd. company profile

View the public company page for Xtl Biopharmaceuticals Ltd. on 6ix.

Xtl Biopharmaceuticals Ltd. news

Read company news and market updates connected to Xtl Biopharmaceuticals Ltd..

Xtl Biopharmaceuticals Ltd. investor events

Find investor webinars, events, and replay context for Xtl Biopharmaceuticals Ltd..